FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

1582211000001109: Cefalexin 500mg tablets (Viatris UK Healthcare Ltd) 21 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2156841000001112 Cefalexin 500mg tablets (Viatris UK Healthcare Ltd) 21 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2156851000001110 Cefalexin 500mg tablets (Viatris UK Healthcare Ltd) 21 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cefalexin 500mg tablets (Viatris UK Healthcare Ltd) 21 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Cefalexin 500mg tablets (Viatris UK Healthcare Ltd) 21 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Cefalexin 500mg tablets (Viatris UK Healthcare Ltd) 21 tablet Is a Cefalexin 500mg tablets 21 tablet true Inferred relationship Existential restriction modifier
Cefalexin 500mg tablets (Viatris UK Healthcare Ltd) 21 tablet Is pack of Cefalexin 500mg tablets (Viatris UK Healthcare Ltd) false Inferred relationship Existential restriction modifier
Cefalexin 500mg tablets (Viatris UK Healthcare Ltd) 21 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Cefalexin 500mg tablets (Viatris UK Healthcare Ltd) 21 tablet Has active ingredient Cefalexin hydrochloride false Inferred relationship Existential restriction modifier
Cefalexin 500mg tablets (Viatris UK Healthcare Ltd) 21 tablet Has active ingredient Cefalexin false Inferred relationship Existential restriction modifier
Cefalexin 500mg tablets (Viatris UK Healthcare Ltd) 21 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Cefalexin 500mg tablets (Viatris UK Healthcare Ltd) 21 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Cefalexin 500mg tablets (Viatris UK Healthcare Ltd) 21 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Cefalexin 500mg tablets (Viatris UK Healthcare Ltd) 21 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Cefalexin 500mg tablets (Viatris UK Healthcare Ltd) 21 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Cefalexin 500mg tablets (Viatris UK Healthcare Ltd) 21 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Cefalexin 500mg tablets (Viatris UK Healthcare Ltd) 21 tablet Has AMP Cefalexin 500mg tablets (Viatris UK Healthcare Ltd) true Inferred relationship Existential restriction modifier
Cefalexin 500mg tablets (Viatris UK Healthcare Ltd) 21 tablet Has specific active ingredient Cefalexin true Inferred relationship Existential restriction modifier
Cefalexin 500mg tablets (Viatris UK Healthcare Ltd) 21 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Cefalexin 500mg tablets (Viatris UK Healthcare Ltd) 21 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start